Numerical aberrations of chromosomes 9 and 11 detected by FISH in Greek bladder cancer patients

Anticancer Research

Volumn 24, Issue 6, 2004, Pages 3857-3861

  Panani, Anna D ^a   Babanaraki, Athanasia ^a   Malianga, Ekaterini ^a   Roussos, Ch ^a  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

Author keywords

Bladder cancer; Chromosomes 9 and 11; Fluorecence in situ hybridization; Interphase cytogenetics

Indexed keywords

BIOLOGICAL MARKER;

ARTICLE; BLADDER CANCER; CANCER GRADING; CANCER RISK; CANCER SCREENING; CHROMOSOME 11; CHROMOSOME 9; CHROMOSOME ABERRATION; CLINICAL ARTICLE; CORRELATION ANALYSIS; CYTOGENETICS; DNA PROBE; ENVIRONMENTAL FACTOR; FLUORESCENCE IN SITU HYBRIDIZATION; GREECE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MONOSOMY; MONOSOMY 9; PATHOGENESIS; PRIORITY JOURNAL; RISK FACTOR; ANEUPLOIDY; BLADDER TUMOR; CANCER STAGING; GENETICS; PATHOLOGY;

ANEUPLOIDY; CHROMOSOMES, HUMAN, PAIR 11; CHROMOSOMES, HUMAN, PAIR 9; GREECE; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; MONOSOMY; NEOPLASM STAGING; URINARY BLADDER NEOPLASMS;

EID: 14944384303     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Van Tilborg AA and Van Rhijn BW: Bladder: Urothelial carcinomas. Altas Genet Cytogenet Oncol Hematol October 2003. Available at: http://www.infobiogen. fr/services/chromcancer/Tumors/blad 5001.html.
2. Gibas Z and Gibas L: Cytogenetics of bladder cancer. Cancer Genet Cytogenet 95: 108-115, 1997.
3. Sandberg AA: Cytogenetics and molecular genetics of bladder cancer: a personal view. Am J Med Genet (Semin Med Genet) 115: 173-182, 2002.
4. Fadl-Elmula I, Gorunova L, Mandabl N, Elfving P, Lundgren R, Mitelman F and Heim S: Karyotypic characterization of urinary bladder transitional cell carcinomas. Genes Chromos Cancer 29: 256-265, 2000.
5. Fadl-Elmula I, Kytola S, Pan Y, Lui WD, Derienzo G, Forsberg L, Mandahl N, Gorunova L, Bergerheim USR, Heim S and Larsson C: Characterization of chromosomal abnormalities in uroepithelial carcinomas by G - banding, spectral karyotyping and FISH analysis. Int J Cancer 92: 824-31, 2001.
6. Sandberg AA and Barger CS: Review of chromosome studies in urological tumors: II Cytogenetics and molecular genetics of bladder cancer. J Urol 151: 545-560, 1994.
7. Poddighe PJ, Pringuier P-P, Vallinga M, Schalken JA, Ramaekers FCS and Hopman AHN: Loss of chromosome 9 in tissue sections of transitional cell carcinomas as detected by interphase cytogenetics. A comparison with RFLP analysis. J Pathol 179: 169-176, 1996.
8. Voorter CE, Ummelen MI, Ramaekers FS and Hopman AH: Loss of chromosome 11 and 11p/q imbalances in bladder cancer detected by fluorescence in situ hybridization. Int J Cancer 65: 301-307, 1996.
9. Hoglund M, Sall T, Heim S, Mitelman F, Mandahl N and Fadl-Elmula I: Identification of cytogenetic subgroups and karyotypic pathways in transitional cell carcinoma. Cancer Res 61: 8241-8246, 2001.
10. Webster LR, McKenzie GH and Moriarty HT: Organophospate-based pesticides and genetic damage implicated in bladder cancer. Cancer Genet Cytogenet 133: 112-117, 2002.
11. Brennan P, Poguillot O, Cordier S, Greiser E, Schill W, Vineis P, Lopez Abente G, Tzonou A, Chang Claude J, Bolm Audorff U et al: Cigarette smoking and bladder cancer in men: a pooled analysis of 11 case - control studies. Int J Cancer 86: 289-294, 2000.
12. Khaled HM, Aly MS and Magrath IT: Loss of Y chromosome in Bilharzial bladder cancer. Cancer Genet Cytogenet 117: 32-36, 2000.
13. Mostoli FK, Sobin LH and Torloni H (eds): Histological Typing of Urinary Bladder Tumors. 1st edition. International Histological Classification of Tumors 10. Geneva, World Health Organization, 1973.
14. Harmer MH: TNM Classification of Malignant Tumors, 3rd edition, Geneva: International Union Against Cancer 111, 1978.
15. Holmang S, Hedelin H, Anderstrom C, Holmberg E and Johansson SL: The importance of the depth of invasion in stage T, bladder carcinoma: a prospective cohort study. J Urol 157: 800-803, 1997.
16. Panani AD, Ferti AD, Avgerinos A and Raptis SA: Numerical aberrations of chromosome 8 in gastric cancer detected by fluorescence in situ hybridization. Anticancer Res 24: 155-160, 2004.
17. Hopman AHN, Ramaekers FCS, Raap AK, Beck JLM, Deville P, Ploeg M and Vooij's GP: In situ hybridization as a tool to study numerical aberrations in solid bladder tumors. Histochemistry 89: 307-316, 1988.
18. Strefford IC, Lillington DM, Steggall M, Lane TM, Nouri AME, Young BD and Oliver RTD: Novel chromosome findings in bladder cancer cell lines detected with multiplex fluorescence in situ hybridization. Cancer Genet Cytogenet 135: 139-146, 2002.
19. Stamouli M, Panani AD, Ferti AD, Petraki C, Oliver RTD, Raptis SA and Young BD: Detection of genetic alterations in primary bladder carcinoma with bicolour and multiplex fluorescence in situ hybridization. Cancer Genet Cytogenet 149: 107-113, 2004.
20. Orntoft TF, Thykjaer T, Waldman FM, Wolf H and Celis JE: Genome-wide study of gene copy numbers, transcripts and protein levels in pairs of non-invasive and invasive human transitional cell carcinomas. Mol Cell Proteomics 1: 37-45, 2002.
21. Habutsi T, Devlin J, Elder PA and Knowles MA: Detailed deletion mapping of chromosome 9 in bladder cancer: evidence for two tumor suppressor loci. Oncogene 11: 1671-1674, 1995.
22. Williamson MP, Elder PA, Shaw ME, Devlin J and Knowles MA: P16 (CDKN2) is a major deletion target at 9p21 in bladder cancer. Hum Mol Genet 4: 1569-1577, 1995.
23. Cairns P, Tokino K, Eby Y and Sidransky D: Homozygons deletions of 9p21 in human bladder tumours detected by comparative multiplex polymerase chain reaction. Cancer Res 54: 1422-1424, 1994.
24. Ishiwata S, Takahashi S, Homma Y, Tanaka Y, Kameyama S, Hosaka Y and Kitamura T: Noninvasive detection and prediction of bladder cancer by fluorescence in situ hybridization analysis of exfoliated urothelial cells in voided urine. Urology 57: 811-815, 2001.
25. Inoue T, Nasu Y, Tsushima T, Miyaji Y, Murakami T and Kumon H: Chromosomal numerical aberrations of exfoliated cells in the urine detected by fluorescence in situ hybridization: clinical implication for the detection of bladder cancer Urol Res 28: 57-61, 2000.
26. Junker K, Werner W, Mueller C, Ebert W, Schubert J and Claussen U: Interphase cytogenetic diagnosis of bladder cancer on cell from urine and bladder washing. Int J Oncol 14: 309-313, 1999.
27. Bartlett JM, Watters AD, Ballantyne SA, Going JJ, Grigor KM and Cooke TG: Is chromosome 9 loss a marker of disease recurrence in transitional cell carcinoma of the urinary bladder? Br J Cancer 77: 2193-2198, 1998.
28. Nemoto R, Nakamura I, Uchida K and Harada M: Numerical chromosome aberrations in bladder cancer detected by in situ hybridization. Br J Urol 75: 470-476, 1995.
29. Acar H, Kilinc M, Yildirim MS, Kaynak M and Cenker A: Evaluation of chromosome 8 and 11 aneuploidies in washings and biopsy materials of bladder transitional cell carcinoma. Cancer Genet Cytogenet 142: 25-29, 2003.
30. Awata S, Sakagami H, Tozawa K, Sasaki S, Veda K and Kohri K: Aberration of chromoses 8 and 11 in bladder cancer as detected by fluorescence in situ hybridization Urol Res 28: 185-190, 2000.
31. Proctor AJ, Coombs LM, Cairns JP and Knowles MA: Amplification of chromosome 11q13 in transitional cell tumors of the bladder. Oncogene 6: 789-795, 1991.
32. Brungier PP, Tamimi Y, Shuuring E and Schalken J: Expression of cyclin D1 and EMS1 in bladder tumors: relationship with chromosome 11q13 amplifications. Oncogene 12:1747-1753, 1996.
33. Veltman JA, Fridlyand J, Pejavar S, Olshen AB, Korkola JE, DeVries S, Carroll P, Kuo W-L, Pinkel D, Albertson D, Cordon-Cardo C, Jain AN and Waldman FM: Array-based comparative genomic hybridization for genome-wide screening of DNA copy number in bladder tumors. Cancer Res 63: 2872-2880, 2003.